Open main menu
Search Ctrl + K
Sign up for free
Loading...
Abcellera Biologics Inc.
Watch
Pharmaceutical Preparations
NASDAQ.ABCL
2215 Yukon Street, Vancouver, A1, V5y 0a1
Categorized
Chronological
Ownership by Owner
Insider Transactions
Institutional Owners
Filings by Form Type
Transcripts
Your Highlights
Search Within Documents
Key Exhibits
Articles & Bylaws
Indentures
Material contracts
Plans of Reorganization
Underwriting Agreements
External Links
Google Finance
SEC EDGAR
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Ownership
4
Thermopylae Holdings Ltd.
29 Aug 24
4
Hayden Michael R
24 Jun 24
4
Lo Andrew
24 Jun 24
4
Montalbano John S.
24 Jun 24
4
Lecault Veronique
24 Jun 24
4
Hansen Carl L. G.
03 Jun 24
4
Hansen Carl L. G.
27 Feb 24
Proxies
DEF 14A
Definitive Proxy Statement Provided In Advance Of A Shareholder Meeting.
29 Apr 24
DEFA14A
Additional Definitive Proxy Soliciting Materials And Rule 14(a)(12) Material.
29 Apr 24
DEFA14A
Additional Definitive Proxy Soliciting Materials And Rule 14(a)(12) Material.
28 Apr 23
DEF 14A
Definitive Proxy Statement Provided In Advance Of A Shareholder Meeting.
28 Apr 23
DEFA14A
Additional Definitive Proxy Soliciting Materials And Rule 14(a)(12) Material.
28 Apr 22
DEF 14A
Definitive Proxy Statement Provided In Advance Of A Shareholder Meeting.
28 Apr 22
DEF 14A
Definitive Proxy Statement Provided In Advance Of A Shareholder Meeting.
28 Apr 21
Other
ARS
Scanned Paper Annual Report Submission.
29 Apr 24
ARS
Scanned Paper Annual Report Submission.
28 Apr 23
EFFECT
Notice Of Effectiveness For A Previously Filed Sec Document.
11 Aug 22
UPLOAD
Letter From The Sec.
28 Jul 22
CORRESP
Correspondence With The Sec.
22 Jul 22
10-K/A
Fiscal Year 2022
22 Jul 22
UPLOAD
Letter From The Sec.
14 Jul 22
News
8-K
Results Of Operations And Financial Condition, Regulation Fd Disclosure, Financial Statements And Exhibits
06 Aug 24
8-K
Submission Of Matters To A Vote Of Security Holders
13 Jun 24
8-K
Results Of Operations And Financial Condition, Regulation Fd Disclosure, Financial Statements And Exhibits
07 May 24
8-K
Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers: Compensatory Arrangements Of Certain Officers, Financial Statements And Exhibits
23 Feb 24
8-K
Results Of Operations And Financial Condition, Regulation Fd Disclosure, Financial Statements And Exhibits
20 Feb 24
8-K
Other Events
28 Nov 23
8-K
Results Of Operations And Financial Condition, Regulation Fd Disclosure, Financial Statements And Exhibits
02 Nov 23
Financials
10-Q
Quarterly Filing
06 Aug 24
10-Q
Quarterly Filing
07 May 24
10-Q
Quarterly Filing
02 Nov 23
10-Q
Quarterly Filing
03 Aug 23
10-Q
Quarterly Filing
04 May 23
10-K
Fiscal Year 2023
21 Feb 23
10-Q
Quarter 3
08 Nov 22
Prospectuses and Registrations
S-8
Registration Of Securities To Be Offered To Employees In Employee Benefit Plans.
20 Feb 24
S-8
Registration Of Securities To Be Offered To Employees In Employee Benefit Plans.
21 Feb 23
POS AM
Post-effective Amendment To An S-1 Or Other Registration Form.
22 Jul 22
POS AM
Post-effective Amendment To An S-1 Or Other Registration Form.
25 Feb 22
S-3ASR
Automatic Shelf Registration Statement Of Securities By Well-known Seasoned Issuers.
25 Feb 22
S-8
Registration Of Securities To Be Offered To Employees In Employee Benefit Plans.
25 Feb 22
424B3
Prospectus Filed Pursuant To Rule 424(b)(3).
16 Feb 22